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Table 1
Correlation matrix of KOOS and MRI variables.
Nvoxel Nvoxel_Rel MExNvoxel IRExNvoxel IRExME CE_Synovit BLOKS_Effusion MOAKS_Effusion
Nvoxel 1.000
Nvoxel_Rel .499** (p<0.0001) 1.000
MExNvoxel .985** (p<0.0001) .508** (p<0.0001) 1.000
IRExNvoxel .948** (p<0.0001) .556** (p<0.0001) .978** (p<0.0001) 1.000
IRExME .815** (p<0.0001) .554** (p<0.0001) .884** (p<0.0001) .950** (p<0.0001) 1.000
CE_Synovit .794** (p<0.0001) .408** (p<0.0001) .823** (p<0.0001) .808** (p<0.0001) .769** (p<0.0001) 1.000
BLOKS_
Effusion
.676** (p<0.0001) .182 (p¼0.080) .682** (p<0.0001) .659** (p<0.0001) .566** (p<0.0001) .474** (p<0.0001) 1.000
MOAKS_
Effusion
.803** (p<0.0001) .242* (p¼0.019) .802** (p<0.0001) .772** (p<0.0001) .673** (p<0.0001) .592** (p<0.0001) .824** (p<0.0001) 1.000
KOOS_Pain -.270** (p¼0.008) -.167 (p¼0.110) -.323** (p¼0.002) -.337** (p¼0.0009) -.370** (p¼0.0002) -.355** (p¼0.0004) -.212* (p¼0.04) -.294** (p¼0.004)
KOOS_Symp -.381** (p¼0.0002) -.177 (p¼0.088) -.428** (p<0.0001) -.463** (p<0.0001) -.471** (p<0.0001) -.386** (p¼0.0001) -.330** (p¼0.001) -.290** (p¼0.005)
KOOS_ADL -.200 (p¼0.053) -.200 (p¼0.053) -.243* (p¼0.018) -.252* (p¼0.014) -.278** (p¼0.007) -.278** (p¼0.007) -.117 (p¼0.262) -.173 (p¼0.095)
KOOS_QOL -.313** (p¼0.002) -.271** (p¼0.008) -.362** (p¼0.0003) -.392** (p<0.0001) -.423** (p<0.0001) -.356** (p¼0.0004) -.189 (p¼0.068) -.298** (p¼0.003)
KOOS_
SportRec
-.228* (p¼0.027) -.236* (p¼0.022) -.278** (p¼0.007) -.289** (p¼0.005) -.320** (p¼0.002) -.307** (p¼0.003) -.127 (p¼0.068) -.127 (p¼0.222)
Spearman's rho with p-values in parentheses.
**Correlation is signiﬁcant at the 0.01 level (2-tailed).
*Correlation is signiﬁcant at the 0.05 level (2-tailed).
Nvoxel: Sum of voxels with plateau and washout enhancement patterns. Nvoxel_Rel: Nvoxel over the total number of enhancing voxels. IRE: Initial rate of enhancement; ME:
Maximal enhancement; CE_Synovitis: Whole-knee synovitis score (on CE-MRI); BLOKS_Effusion: Boston-Leeds OA Knee Score effusion score (CE-MRI); MOAKS_Effusion: MRI
in OA Knee Score effusion-synovitis score (non CE-MRI); KOOS: Knee injury and OA Outcome Score; Symp: Symptoms; ADL: Activity in Daily Living; QOL: Quality of Life;
SportRec: Sport/Recreation.
Table 1
Adjusted odds ratios and 95% conﬁdence intervals for measures of alignment pre-
dicting MFTC/LFTC progressors and non-progressors from baseline to 1-year follow-
up.
Alignment MFTC LFTC
adjOR 95%CI p adjOR 95%CI p
HKA 3.17 1.80, 5.58 <0.001 2.31 1.22, 4.35 0.010
FTA (with offset) 3.05 1.83, 5.89 <0.001 2.67 1.38, 5.17 0.003
FTA (without offset) 2.17 0.88, 5.31 0.091 0.64 0.11, 3.77 0.626
Goniometer 1.65 0.90, 3.03 0.108 1.71 1.01, 2.90 0.045
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ANATOMICAL ALIGNMENT, BUT NOT GONIOMETRY, PREDICTS
FEMOROTIBIAL CARTILAGE LOSS AS WELL AS MECHANICAL
ALIGNMENT
R. Moyer y, W. Wirth z, F. Eckstein z. yUniv. of Western Ontario, London,
ON, Canada; z Paracelsus Med. Univ. Salzburg & Nuremberg, Salzburg,
Austria
Purpose: Frontal plane lower limb alignment has important associa-
tions with the distribution of load in the femorotibial joint and with the
location and magnitude of structural progression of knee osteoarthritis
(OA). Alignment is conventionally determined as the mechanical axis
(or hip-knee-ankle [HKA]) angle from full limb radiographs. Yet, other,
simpler measures of frontal plane alignment exist, including a new
method for measuring the anatomical axis (or femorotibial angle [FTA])
from ﬁxed ﬂexion radiographs, aligned with measures of radiographic
joint space. However, it is unclear how this measure, or non-radio-
graphic goniometry, predict cartilage thickness loss as measured
quantitatively with MRI in relation to HKA. The objective of the current
study was hence to identify how this new FTAmeasure and goniometry
predict medial and lateral cartilage thickness loss from MRI compared
with the HKA gold standard.
Methods: Participants were selected from the Osteoarthritis Initiative
(OAI). 450 knees were available with baseline and 1-year follow-up
MRI measurements (coronal FLASH acquisitions) and 489 with
baseline and 2-year follow-up MRI (sagittal DESS). Knees with
incomplete measures of frontal plane alignment or with Kellgren and
Lawrence grade <2 (no deﬁnite radiographic OA) were excluded.
Progression was deﬁned as cartilage thickness loss exceeding the
smallest detectable change (SDC) in the medial (MFTC: -102mm
[FLASH], -111mm [DESS]) or lateral femorotibial compartment (LFTC:
-92mm [FLASH], -121mm [DESS]), respectively. HKA, FTA and goni-
ometer measures were categorized into (a) neutral, (b) varus and (c)
valgus. Neutral HKA and goniometer angles were deﬁned as -2 to 2.
Based on a previously determined offset across all OAI participants
with FTA and HKA measurements, a neutral FTA was deﬁned as -6.3
to -2.3. Correlations between cartilage loss and alignment measures
were determined by calculating Pearson coefﬁcients. Logistic
regression models were used to determine the odds of medial andlateral progression in varus and valgus knees, measured by each
alignment method, and using neutral knees as a reference. All models
were adjusted for age, sex and body mass index.
Results: Correlations of MFTC/LFTC cartilage thickness loss between
baseline and 1-year follow-up were largest for HKA (r¼0.21/-0.19) and
somewhat lower for FTA (r¼0.15/-0.13) and goniometry (r¼0.12/-0.11).
Correlations of cartilage loss between baseline and 2-year follow-up
were similar for HKA (r¼0.28/-0.29) and FTA (r¼0.28/-0.30) and lower
for goniometry (r¼0.11/-0.16). When applying the 4.3 valgus offset to
the 1-year follow-up cohort, the new FTA alignment measure pre-
dicted MFTC progression (adjOR¼3.05) and LFTC progression
(adjOR¼2.67) as well as the HKA gold standard (adjOR¼3.17 and 2.31,
respectively, Table 1). Without using the offset, the prediction by the
new measurement was less strong. In the 2-year follow-up cohort, FTA
appeared to be a better predictor for MFTC progression (adjOR¼2.44)
and LFTC progression (adjOR¼3.40) than the HKA gold standard
(adjOR ¼ 1.66 and 2.24, respectively, Figure 1). Without using the FTA
offset, the new measurement was a good predictor of MFTC pro-
gression (adjOR¼4.09), but not LFTC progression. Goniometry was a
weak predictor for MFTC and LFTC progression in both cohorts (Table
1; Figure 1).
Conclusions: Compared to the gold standard of measuring mechanical
alignment using full limb radiographs (HKA), the new FTA measurement
wasat least asgood inpredictingMFTC/LFTC cartilage thickness losswhen
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A225accounting for the systematic offset between bothmethods. Goniometry,
in contrast, was a poor predictor formedial and lateral cartilage thickness
loss. If the FTA offset is not adjusted for, the new method of measuring
alignment from ﬁxed ﬂexion radiographs is shifted in the varus direction,
and has limited ability to predict future LFTC cartilage loss.
Figure 1. Adjusted odds ratios and 95% conﬁdence intervals for measures
of alignment predicting MFTC/LFTC progressors and non-progressors from
baseline to 2-year follow-up.
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CLINICAL SIGNIFICANCE OF A KNEE EFFUSION DETECTED ON
PHYSICAL EXAMINATION IN A PATIENT WITH KNEE OA
J.L. Jaremko, D. McDougall, B. Smith, R.G. Lambert, W.P. Maksymowych.
Univ. of Alberta, Edmonton, AB, Canada
Purpose: With recent focus on the potentially treatable inﬂammatory
component of osteoarthritis (OA), there has been increased interest in
the detection and implications of a joint effusion as a marker of
inﬂammation. Effusions can be detected clinically, primarily via tap and
bulge signs on physical examination. However, there has been sur-
prisingly little objective evaluation of these clinical signs, perhaps
because presence of an effusion at imaging is also somewhat subjective.
Using clinical and imaging data from the Osteoarthritis Initiative, we
sought to determine (1) sensitivity and speciﬁcity of the tap and bulge
signs for the presence of a joint effusion on MRI as measured by two
semi-quantitative scoring systems, and (2) the clinical implication of an
effusion detected on physical examination in terms of pain and dis-
ability at presentation and the rate of use of intra-articular steroid
injection over the next year.
Methods: Patients: This retrospective cohort study includes knees from
40 subjects from the Osteoarthritis Initiative (OAI) that went on to have
a knee steroid injectionwithin 1 year of baseline evaluation, and 40 that
did not, matched by age, sex, and Kellgren-Lawrence (K-L) grade of
radiographic OA. Age averaged 62.3 years (range: 45-78), K-L grade
2.8±1.0 (mean±standard deviation), 78% were women, and body mass
index (BMI) averaged 30.3±4.6.
Clinical data: In addition to demographics above, the variables extrac-
ted from OAI included at baseline visit (year 0) the tap and bulge signs
for effusion (positive/negative), Western Ontario & McMaster
(WOMAC) pain and status scores.
MRI evaluation for effusion: After initial consensus training, two mus-
culoskeletal radiologists separately scored each knee on two semi-
quantitative effusion scores: MOAKS, which grades the whole joint by a
single number from 0 (no effusion) to 3 (large effusion), and KIMRISS,
where the depth of joint ﬂuid is measured and graded at four sites on
axial and sagittal MRI (medial, lateral and superior suprapatellar
recesses and Baker cyst), then summed for a score from 0-12.
Statistics: The tap sign was highly insensitive (only four positive cases)
and not examined further. We compared the prevalence and size of
effusions at MRI in patients with positive and negative bulge sign using
nonparametric Mann-Whitney U test. We computed sensitivity/specif-
icity of the bulge sign for detecting an effusion visible at MRI at various
MOAKS and KIMRISS thresholds. In bulgeþ and bulge- cohorts we
compared WOMAC pain and status scores at baseline and the rates of
steroid injections in that knee after 1 year, all by Mann-Whitney U test.
Results: Effusion prevalence was high at MRI (MOAKS >¼1 in 70%,
KIMRISS >¼4 in 72%). The bulge-positive knees (n¼18) had signiﬁcantly
larger effusions than bulge-negative knees (n¼62), whether by MOAKS(1.3±0.1 vs. 0.8±0.1, p¼0.01) or KIMRISS (5.6±0.3 vs. 4.2±0.3, p¼0.02;
Figure 1). In the full data set, sensitivity for an effusion was optimal at
thresholds of MOAKS 1 or KIMRISS 4, at 0.3-0.32, with speciﬁcity 0.83-
1.0, and there was no signiﬁcant difference in WOMAC pain or status
scores between bulgeþ/bulge-¼ knees. However, when analysis was
limited to non-obese patients (BMI<30, n¼36), sensitivity improved
slightly, to 0.38-0.39, and the bulgeþ knees (n¼9) had substantially
higher average WOMAC scores than others (pain 5.1 vs 2.1, p¼0.003,
status 23.8 vs 10.0, p¼0.004). Within the year after initial observation,
14/18 (77%) of the bulgeþ group had received steroid injections in that
knee, vs. 26/62 (42%) of the bulge- group (p¼0.007).
Conclusions: Signs of knee effusion on physical examination are
insensitive, especially in obese patients, and the tap sign is so rarely
positive as to be of little value. When an effusion is detected by bulge
sign in a patient with established knee OA, it is associated with a larger
knee effusion at MRI, signiﬁcantly greater current pain and disability,
and a signiﬁcantly higher rate of steroid injections into that knee in the
next year than if no effusion is detected clinically. These associations
support the notion that a joint effusion reﬂects active synovitis, and
encourage careful clinical examination for knee effusions.
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PATELLO-FEMORAL OSTEOARTHRITIS AT BASELINE IS PREDICTIVE
FOR TIBIO-FEMORAL OSTEOARTHRITIS FIVE YEARS LATER AND
VICE VERSA
D. Schiphof, E.H. Oei, E.J. Waarsing, S.M. Bierma-Zeinstra. Erasmus MC,
Rotterdam, Netherlands
Purpose: The awareness of the importance of patellofemoral osteo-
arthritis (PFOA) is increasing in recent years. Suggested is that PFOA is
the precursor of tibiofemoral OA. Is PFOA at baseline predictive for TFOA
ﬁve years later? The other way aroundmight also be possible, so is TFOA
at baseline predictive for PFOA ﬁve years later.
Methods: Of a random subsample (n¼337) of the 891 females (aged 45-
60) from the nested cohort of the Rotterdam Study, baseline and 5-years
follow-up MRIs of both knees were assessed for knee OA with the MRI
Osteoarthritis Knee Scoring (MOAKS). Based on these scored features
we applied the proposed MRI deﬁnition. We distinguished the
PFOAMRI-deﬁnition from the TFOAMRI-deﬁnition. X-rays of both knees
were scored with Kellgren and Lawrence classiﬁcation criteria (K&L).
Binomial logistic generalized estimated equations were used to deter-
mine the predictive value of PFOAMRI for TFOAMRI at follow-up. For
this analysis we excluded the knees with TFOA at baseline. We adjusted
the analysis for age and BMI and for K&L-score at X-ray of the TF- joint.
In addition, we did the same analysis to test if TFOA in knee without
PFOA at baseline was predictive for PFOA at 5 year follow-up.
Results: Figure 1 shows the distribution and shift during follow-up of
the knees deﬁned with isolated PFOAMRI, isolated TFOAMRI, combined
PF&TFOAMRI and knees without OA of the ﬁrst 337 women of whom
MRIs are scored. At baseline mean age is 54.9 years (sd¼3.9) and mean
BMI is 26.9 kg/m2 (sd¼4.3). Mean follow-up time is 5.1 years (sd¼0.4).
